Noncanonical NF-kappa B signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation

Sander W. Tas, Margriet J. Vervoordeldonk, Najat Hajji, Joost H. N. Schuitemaker, Koen F. van der Sluijs, Michael J. May, Sankar Ghosh, Martien L. Kapsenberg, Paul P. Tak, Esther C. de Jong

Research output: Contribution to journalArticleAcademicpeer-review

133 Citations (Scopus)

Abstract

Ligation of CD40 on dendritic cells (DCs) induces early production of inflammatory mediators via canonical NF-kappa B signaling, as well as late expression of the anti inflammatory enzyme indoleamine 2,3dioxygenase (IDO) via unknown signal transduction. By selective blocking of either the canonical NF-kappa B pathway using the NEMO-binding domain peptide or the noncanonical NF-kappa B pathway by small interfering RNA, we demonstrate that IDO expression requires noncanonical NF-kappa B signaling. Also, noncanonical NF-kappa B signaling down-regulates proinflammatory cytokine production in DCs. In addition, selective activation of the noncanonical NF-kappa B pathway results in noninflammatory DCs that suppress T-cell activation and promote the development of T cells with regulatory properties. These findings reveal an important role of the noncanonical NF-kappa B pathway in the regulation of immunity
Original languageEnglish
Pages (from-to)1540-1549
JournalBlood
Volume110
Issue number5
DOIs
Publication statusPublished - 2007

Cite this